Abstract
Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Current Genomics
Title: Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer
Volume: 1 Issue: 1
Author(s): I. Sanchez-Garcia
Affiliation:
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Abstract: Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Export Options
About this article
Cite this article as:
Sanchez-Garcia I., Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351814
DOI https://dx.doi.org/10.2174/1389202003351814 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) A Medicinal Chemist’s Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents
Current Topics in Medicinal Chemistry One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Application of Stem Cell Therapy During the Treatment of HIV/AIDS and Duchenne Muscular Dystrophy
Current Stem Cell Research & Therapy Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Chemical Advances in Therapeutic Application of Exosomes and Liposomes
Current Medicinal Chemistry Topoisomerase I and II Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery The Inhibitory Effect of Cyclosporine A and Prednisolone on Both Cytotoxic CD8+ T Cells and CD4+CD25+ Regulatory T Cells
Current Signal Transduction Therapy Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
Current Medicinal Chemistry MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets
Current Drug Targets Biologics for ANCA-Associated Vasculitis
Inflammation & Allergy - Drug Targets (Discontinued) From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Meet Our Editorial Board Member
Current Organic Synthesis Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
Recent Patents on Anti-Cancer Drug Discovery Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)